HSBC Holdings
CLBT icon

HSBC Holdings’s Cellebrite CLBT Stock Holding History

HSBC Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-52,317
Closed -$1.14M – 3073
2024
Q4 		$1.14M Sell
52,317
-42,770
-45% -$823K ﹤0.01% 1728
2024
Q3 		$1.62M Sell
95,087
-142,915
-60% -$2.12M ﹤0.01% 1508
2024
Q2 		$2.87M Buy
238,002
+73,533
+45% +$821K ﹤0.01% 1257
2024
Q1 		$1.82M Buy
164,469
+89,635
+120% +$915K ﹤0.01% 1524
2023
Q4 		$648K Buy
+74,834
New +$582K ﹤0.01% 1943

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings's CLBT Position: Q1 2025 in Review

HSBC Holdings sold out of Cellebrite (CLBT) in Q1 2025, closing a stake of 52,317 shares — an estimated $1.14M sold.

HSBC Holdings first reported a position in CLBT in Q4 2023 and held it in 5 quarters. The position peaked at $2.87M in Q2 2024. 199 funds tracked by Wall St. Rank hold CLBT as of Q1 2025.

  • HSBC Holdings reported no remaining Cellebrite position as of Q1 2025 after selling out during the quarter.
  • HSBC Holdings sold 52,317 Cellebrite shares in Q1 2025, an estimated $1.14M.
  • HSBC Holdings first reported a position in Cellebrite in Q4 2023 and held it in 5 quarters.
  • HSBC Holdings's Cellebrite position peaked at $2.87M in Q2 2024.
  • 199 funds tracked by Wall St. Rank held Cellebrite as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.